What Should we Measure? A Qualitative Interview Study on Outcomes for Evaluating AI-assisted Medical Image Interpretation.
2 other identifiers
observational
30
1 country
1
Brief Summary
Background: AI (artificial intelligence) tools are increasingly used to help clinicians interpret medical images such as X-rays, scans, skin photographs and eye images. In most cases the AI does not work alone: a clinician makes the final decision, using the AI as support. Before these tools are used in the NHS, they must be tested to show they are safe and helpful. They are usually tested in a "reader study", where several clinicians each interpret the same set of images, sometimes with the AI's help and sometimes without, so performance can be compared. These studies tend to focus on whether the diagnosis was correct. However, accuracy alone may not measure everything that matters. For example, what happens when the AI gets it wrong, whether clinicians rely on it too much or too little, or how the tool affects efficiency. At present there is no agreed standard for what these studies should measure, so important things are often missed and studies are hard to compare. Aim: The aim of this study is to find out, by talking to people with different perspectives, which outcomes are important when evaluating AI tools that help clinicians read medical images. Objectives:
- 1.Explore which outcomes people think matter when judging whether an AI tools is safe and good enough to use
- 2.Understand the reasons behind their views
- 3.Explore how priorities differ between groups, such as patients and developers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2026
CompletedStudy Start
First participant enrolled
October 16, 2026
CompletedFirst Posted
Study publicly available on registry
October 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 16, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 16, 2027
October 21, 2026
October 1, 2026
9 months
October 8, 2026
October 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Qualitative themes and subthemes
Day 1 (interview date) through study completion (1 year)
Secondary Outcomes (1)
Number of participants per stakeholder group
Day 1
Other Outcomes (3)
Participant age
Day 1
Participant sex
Day 1
Participant professional background
Day 1
Study Arms (6)
Patients and the public
Clinicians
Representatives of UK regulatory bodies
Researchers and methodologists
Hospital managers and procurers
Developers of AI image-interpretation tools
Eligibility Criteria
The investigators expect to involve approximately 24-30 participants in total, each taking part in a single interview. Participants will be purposively sampled across the following stakeholder groups, with roughly equal numbers. A key priority is to achieve a rich spread of perspectives within and across the groups.
You may qualify if:
- Membership of one of the following stakeholder groups:
- Clinicians who interpret medical images (e.g. radiologists, dermatologists, ophthalmologists, pathologists, and trainees in these specialties)
- Researchers and methodologists who design or analyse studies of these tools
- Developers of AI image-interpretation tools
- Regulatory, health-technology-assessment and policy stakeholders
- Patients and members of the public, including people affected by conditions diagnosed using medical imaging
- Hospital managers and procurers
You may not qualify if:
- Involvement in study design
- Unable to speak fluent English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences
Oxford, OX37LD, United Kingdom
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Dominic Furniss, DM MA MBBCh FRCS
University of Oxford
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2026
First Posted
October 21, 2026
Study Start
October 16, 2026
Primary Completion (Estimated)
July 16, 2027
Study Completion (Estimated)
October 16, 2027
Last Updated
October 21, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share
Qualitative interview data may include sensitive personal health, commercial, or regulatory information.